This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Explore actionable, evidence-based strategies to combat traditional and emerging riskfactors, with a focus on precision approaches and primordial prevention. Precision Medicine: Personalizing Prevention for Better Outcomes Precision medicine provides tools to customize prevention and treatment plans based on individual riskfactors.
Black History Month is a poignant backdrop to the alarming rise in obesity and type 2 diabetes, particularly among those of marginalized populations. Furthermore, research on intergenerational trauma shows how stressors can pass on to the next generation, setting the stage for generations of health inequality. #1
Every year, the AHA reports the most up-to-date statistics related to heart disease, stroke, and cardiovascular riskfactors. In 2010, the AHA released a 2020 goal to improve the CV health of all Americans by 20%, while reducing CVD and stroke deaths by 20%. From 2017 to 2020, adult obesity prevalence in the U.S.
to 26.8%) and obesity (43.1% Most adverse trends are projected to be worse among people identifying as American Indian/Alaska Native or multiracial, Black, or Hispanic.CONCLUSIONS:The prevalence of many cardiovascular riskfactors and most established diseases will increase over the next 30 years. in 2020 to 61.0%
Obesity is a widespread publichealth challenge in the Middle East, maintaining prevalence in 54.2% Overweight and obese women have a higher risk of hypertension and cardiovascular riskfactors than women with a standard BMI, according to an analysis of the ANCORS-YW STUDY presented at ACC Middle East 2024.
Cardiovascular disease (CVD) is a critical publichealth concern, with riskfactors such as high blood pressure, abnormal blood sugar levels, elevated cholesterol, and obesity beginning in childhood.
These data offer an updated analysis of health estimates pertaining to the worldwide, regional, and national impact of cardiovascular diseases (CVD) and associated riskfactors. High systolic blood pressure stands out as a major riskfactor, directly contributing to leading cardiovascular causes of death in LMICs.
Aims:Asian Americans experience disproportionate burdens of cardiovascular riskfactors and cardiovascular disease (CVD). However, the trends in cardiovascular risks in adults from different Asian ethnic backgrounds remain understudied. Asian Indian adults exhibited uptrends in overweight/obesity (AAPC: 1.1%,p<
The AHA strives to further understand and help heal health problems inflicted by structural racism, a publichealth crisis that can significantly damage physical and mental health and perpetuate disparities in access to health care, education, income, housing, and several other factors vital to healthy lives.
School of PublicHealth at UT Southwestern. Some people have high apoB but a relatively low LDL-C, so their heart disease risk is underestimated by not measuring apoB. Others may have a high LDL-C but a low or normal apoB, and they aren’t at risk.” But even people without these conditions can have discordance.
The Growing Global Burden of AFib The global incidence of AFib is on the rise, making it a significant publichealth concern. Factors such as aging populations, rising rates of obesity, hypertension, and other cardiovascular conditions contribute to this increase.
The Growing Global Burden of AFib The global incidence of AFib is on the rise, making it a significant publichealth concern. Factors such as aging populations, rising rates of obesity, hypertension, and other cardiovascular conditions contribute to this increase.
Food and Drug Administration ( FDA ) has approved an additional indication for Wegovy ( semaglutide ) to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight along with a reduced calorie diet and increased physical activity.
We've known for a long time that smoking tobacco is linked to heart disease, and this study is evidence that smoking cannabis appears to also be a riskfactor for cardiovascular disease, which is the leading cause of death in the United States,” Jeffers said. Cannabis use could be an important, underappreciated source of heart disease.”
Conclusion:The global burden of stroke attributable to high BMI in OECD countries highlights the urgent need for comprehensive strategies to address the intertwined challenges of obesity and stroke. Stroke, Volume 55, Issue Suppl_1 , Page AWMP101-AWMP101, February 1, 2024.
In the Sunday Times of April 23 rd , 2017, this article appeared, entitled ‘ Kellogg’s smothers health crisis in sugar – The cereals giant is funding studies that undermine official warnings on obesity.’ The study, published in the Journal Obesity Facts relied on evidence from 14 studies. Just to choose a few paragraphs. ‘
Background Sex differences have not been fully explored for certain riskfactors or by age or age-related factors, such as menopause. Methods UK Biobank participants with ≥1 riskfactor measured at baseline were included. We addressed this issue in a large population cohort. Results 501 389 adults (54.4%
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content